Nanexa says its long-acting subcutaneous technology could reduce the dosing [...]

Informa Markets has unveiled the 2025 speaker line-up for CPHI [...]

Laboratories across the pharmaceutical industry are moving closer to full [...]

Genethon and Hansa Biopharma report GNT-018-IDES trial data showing imlifidase [...]

Grifols has expanded its portfolio of plasma-derived therapies in the [...]

KLIFO, Europe’s largest independent provider of clinical trial supply (CTS) [...]

Axplora has initiated global investments exceeding €100 million in 2025 [...]

BBG Advanced Therapies (BBGAT), a subsidiary of BioBridge Global and [...]

Vitalant has launched a national hub-and-spoke model to expand patient [...]